The Chemours financials
$13.89−1.70%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.83B | $6.34B | $4.97B | $5.53B | $6.64B | $6.18B | $5.40B |
| Gross profit | $902.0M | $1.14B | $1.30B | $1.62B | $1.38B | $1.07B | $1.06B | $1.97B | $1.75B | $1.10B |
| Gross margin | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.2% | 20.4% |
| Operating income | -$64.0M | $319.0M | -$245.0M | $772.0M | $676.0M | $367.0M | $348.0M | $1.18B | $981.0M | -$94.0M |
| Net income | -$386.0M | $69.0M | -$253.0M | $578.0M | $608.0M | $219.0M | -$52.0M | $995.0M | $746.0M | $7.0M |
| Net margin | −6.6% | 1.2% | −4.2% | 8.5% | 9.6% | 4.4% | −0.9% | 15.0% | 12.1% | 0.1% |
| Diluted EPS | $-2.57 | $0.46 | $-1.70 | $3.65 | $3.60 | $1.32 | $-0.32 | $5.45 | $3.91 | $0.04 |
| EBITDA | $335.0M | $727.0M | $217.0M | $1.08B | $999.0M | $767.0M | $746.0M | $1.52B | $1.31B | $360.0M |
| Operating cash flow | $264.0M | -$633.0M | $556.0M | $755.0M | $814.0M | $807.0M | $650.0M | $1.14B | $640.0M | $594.0M |
| Free cash flow | $51.0M | -$993.0M | $186.0M | $448.0M | $537.0M | $540.0M | $169.0M | $642.0M | $229.0M | $256.0M |
| Diluted shares | 150.2M | 150.2M | 148.9M | 158.3M | 168.7M | 166.3M | 164.8M | 182.6M | 191.0M | 183.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $670.0M | $713.0M | $1.20B | $1.10B | $1.45B | $1.10B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $4.14B | $4.11B | $4.04B | $3.63B | $3.75B | $4.03B |
| Total assets | $7.38B | $7.51B | $8.25B | $7.64B | $7.55B | $7.08B |
| Total liabilities | $7.13B | $6.94B | $7.51B | $6.53B | $6.47B | $6.27B |
| Shareholders' equity | $251.0M | $572.0M | $739.0M | $1.11B | $1.08B | $815.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology